JNJ vs BAX
By Alex · Tickerpine
Johnson & Johnson vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BAX |
|---|---|---|
| Price | $263.81 | $25.30 |
| Market cap | $635.07B | $13.08B |
| P/E ratio | 40.0 | — |
| ROE | 20.02% | -14.37% |
| Profit margin | 16.20% | -9.27% |
| Revenue growth | 5.90% | 5.30% |
| Dividend yield | 2.03% | 0.16% |
| Beta | 0.21 | 0.65 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BAX in plain English
- JNJ is the bigger company — about 48.6× the market cap of BAX.
- JNJ earns a higher return on equity (20% vs -14%).
- JNJ is growing revenue faster (6% vs 5%).
- JNJ has the higher dividend yield (2.03% vs 0.16%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.